We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAST
551
DELISTED
Carrols Restaurant Group, Inc.
TAST
$2.11M 0.01%
233,795
-19,090
-8% -$175K
PLD icon
552
Prologis
PLD
$133B
$2.11M 0.01%
26,286
+277
+1% +$21.1K
PBF icon
553
PBF Energy
PBF
$7.31B
$2.1M 0.01%
67,164
+66,664
+13,333% +$1.99M
HRI icon
554
Herc Holdings
HRI
$5.61B
$2.1M 0.01%
45,834
+9,695
+27% +$404K
ITT icon
555
ITT
ITT
$19.1B
$2.09M 0.01%
31,901
+28,601
+867% +$1.75M
SIEN
556
DELISTED
Sientra, Inc.
SIEN
$2.08M 0.01%
33,776
+26,659
+375% +$1.92M
SNP
557
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$2.08M 0.01%
+30,457
New +$2.21M
KEX icon
558
Kirby Corp
KEX
$6.93B
$2.07M 0.01%
26,157
+3,321
+15% +$267K
MYGN icon
559
Myriad Genetics
MYGN
$312M
$2.06M 0.01%
74,267
+73,132
+6,443% +$2.07M
HTZ
560
DELISTED
Hertz Global Holdings, Inc.
HTZ
$2.05M 0.01%
128,535
+83,194
+183% +$1.25M
GLUU
561
DELISTED
Glu Mobile Inc.
GLUU
$2.05M 0.01%
+284,931
New +$2.62M
HQY icon
562
HealthEquity
HQY
$8.75B
$2.04M 0.01%
+31,162
New +$2.17M
MRTX
563
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.03M 0.01%
+19,708
New +$1.53M
LAUR icon
564
Laureate Education
LAUR
$5.28B
$2.01M 0.01%
+127,978
New +$2.04M
ICFI icon
565
ICF International
ICFI
$1.72B
$2.01M 0.01%
27,612
+25,498
+1,206% +$1.91M
HEI.A icon
566
HEICO Corp Class A
HEI.A
$37.2B
$2.01M 0.01%
19,414
+18,484
+1,988% +$1.7M
RCI icon
567
Rogers Communications
RCI
$18.6B
$2M 0.01%
+37,338
New +$1.95M
CHWY icon
568
Chewy
CHWY
$9.63B
$2M 0.01%
+57,126
New +$1.93M
CAR icon
569
Avis
CAR
$5.02B
$2M 0.01%
+56,737
New +$1.9M
GE icon
570
GE Aerospace
GE
$384B
$1.98M 0.01%
+37,872
New +$1.86M
ECPG icon
571
Encore Capital Group
ECPG
$2.13B
$1.97M 0.01%
+58,054
New +$1.88M
CZR
572
DELISTED
Caesars Entertainment Corporation
CZR
$1.95M 0.01%
+165,182
New +$1.56M
HEES
573
DELISTED
H&E Equipment Services
HEES
$1.95M 0.01%
66,882
-125,802
-65% -$3.5M
EPAY
574
DELISTED
Bottomline Technologies Inc
EPAY
$1.93M 0.01%
43,634
+35,083
+410% +$1.63M
ORCL icon
575
Oracle
ORCL
$423B
$1.93M 0.01%
33,795
+11,389
+51% +$616K
21 22
23
24 25

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.